[Form 4] NV5 Global, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 4 discloses that Edward H. Codispoti, Chief Financial Officer of NV5 Global, Inc. (NVEE), no longer holds NVEE common stock following the closing of the company’s merger with Acuren Corporation on 08/04/2025. The filing records a single disposition transaction coded “D” for 89,154 NVEE shares. Pursuant to the May 14 2025 Agreement and Plan of Merger, each NVEE share—including vested restricted-stock awards—was converted into the right to receive 1.1523 Acuren shares plus $10.00 in cash per share. After the conversion, Codispoti’s beneficial ownership in NVEE is 0.

No derivative security transactions were reported. The transaction was filed by one reporting person and was executed under ordinary merger terms; there is no indication of a Rule 10b5-1 trading plan. The filing confirms the equity-for-cash consideration structure and indicates that all insider NVEE equity has been exchanged, signaling the consummation of the merger.

Positive

• Merger consummation confirmed: Filing validates that the NV5–Acuren transaction closed on 08/04/2025 and consideration was delivered as promised.
• Immediate liquidity: Shareholders, including the CFO, receive $10.00 cash per share in addition to Acuren stock.

Negative

• Loss of NVEE insider alignment: CFO now holds zero NVEE shares, ending direct management equity stake in the legacy entity.

Insights

Equity Capital Markets Analyst

TL;DR: Insider’s NVEE stake converted to Acuren stock and cash; confirms merger close, neutral cash-outflow impact.

The disposition of 89,154 shares by the CFO is mechanical—triggered by the merger with Acuren. Because every NVEE shareholder receives identical consideration, the insider sale is not an idiosyncratic signal about valuation or future performance. The filing does, however, corroborate that the merger has closed and that share conversion mechanics have been executed, which may affect float and index membership. Overall impact is neutral for existing NVEE investors (who are now Acuren shareholders) but removes NV5 insider-ownership visibility.

M&A Specialist

TL;DR: Filing evidences completion of NV5–Acuren merger; payout terms exactly as stipulated.

The Form 4 shows automatic vesting of restricted shares and conversion into the agreed merger consideration—1.1523 Acuren shares + $10 cash per NVEE share. No price premium beyond the merger terms is indicated. From a deal-process perspective, this is a routine post-closing administrative step. The elimination of NVEE insider holdings supports the legal merger effective date and simplifies future corporate governance under Acuren. Investor impact is modest; key takeaway is confirmation of deal consummation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Codispoti Edward H

(Last) (First) (Middle)

200 SOUTH PARK RD.

SUITE 350

(Street)

HOLLYWOOD FL 33021

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NV5 Global, Inc. [ NVEE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2025		D		89,154	D	(1)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to the Agreement and Plan of Merger, dated as of May 14, 2025 (the "Merger Agreement"), by and among NV5 Global, Inc. (the "Company"), Acuren Corporation ("Acuren"), Ryder Merger Sub I, Inc. and Ryder Merger Sub II, Inc., each outstanding share of common stock of the Issuer was converted into the right to receive 1.1523 shares of Acuren common stock per share and $10.00 in cash per share (together, the "Merger Consideration"). In addition, pursuant to the Merger Agreement, any outstanding restricted stock award of NV5 held by the Reporting Person automatically vested in full in accordance with its terms immediately prior to the effective time of the mergers and converted into the right to receive the Merger Consideration, less applicable tax withholdings.

	/s/ MaryJo OBrien, as attorney in fact	08/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NV5 Global's CFO report on the Form 4 dated 08/06/2025?

He disposed of 89,154 NVEE shares as part of the merger with Acuren, reducing his NVEE ownership to 0.

What consideration did NV5 shareholders receive in the Acuren merger?

Each NVEE share was converted into 1.1523 Acuren shares plus $10.00 in cash.

Is the insider sale related to a Rule 10b5-1 trading plan?

No. The filing does not indicate that the transaction was executed under a Rule 10b5-1 plan.

Were any derivative securities involved in the transaction?

No derivative securities were reported; only common stock was converted.

How many NVEE shares does the CFO own after the merger?

The CFO owns zero NVEE shares following the reported transaction.